Aquila are exhibiting at Cambridge Healthtech Institute’s 14th Annual Biomarkers and Immuno-Oncology Congress taking place on 11th – 13th June.
If you would like to find out more about our Immunology, Immuno-Oncology or Specialist Histology services, please come and talk to Louise Welch (BD & Marketing), Hayley Gooding (Principal Scientist) and Sevi Giakoumelou (Senior Scientist) at Stand 9.
We will be presenting two posters titled “Biomarker Detection Using a Mixed Multiplex Approach”, showcasing our specialist multiplex histology services and “Interrogation and Modulation of the Immunosuppressive Activity of Human TAM-like Macrophages Using In Vitro Cultures”, highlighting our ex vivo macrophage assays.
To organise a meeting with any member of the team in Boston, please get in touch.
The 14th Annual Biomarkers and Immuno-Oncology Congress is a long running event dedicated to all areas of biomarker research and development spanning the pharmaceutical and diagnostic pipelines. Click here to find out more about the 14th Annual Biomarkers and Immuno-Oncology Congress.
We hope to see you there!